Transparency guideline

Transparency guideline on Lundbeck Japan K. K. and corporate activities in relation to medical institutions. Information about 2014 payments are disclosed below.

1.         Objectives

Lundbeck (Lundbeck Japan K. K. and its headquarters H. Lundbeck A/S) has committed to make utmost efforts to ensure that its corporate activities are to be conducted in an ethically responsible and transparent manner. Lundbeck has established the Corporate Code of Conduct and conducts corporate activities based on the Code of Conduct to maintain its reputation as the socially respected and trusted pharmaceutical company. The Code of Conduct includes a provision regarding maintenance of trust and transparency in the relation with medical institutions, etc. It is Lundbeck Japan’s responsibility to conduct corporate activities in compliance with the in-house policy for transparency and with the JPMA’s “Transparency Guideline for the Relation between Corporate Activities and Medical Institutions” as a pharmaceutical company with focus on (national) citizens’ life and health. This considered, the in-house policy for transparency “Transparency Guidelines on Corporate Activities in Relation to Medical Institutions” was prepared to convey our policy regarding transparency in cooperate activities in relation to medical institutions, etc.

 

2.         Method of disclosure

Lundbeck Japan K. K. will disclose on its website the information on payment/fund granted to medical institutions, etc., in the previous term after the settlement.

 

3.         Timing of disclosure

Information for the results of fiscal year 2014 will be disclosed in 2015 after the closing of the financial accounts for fiscal year 2014. In each year thereafter, information will be disclosed after the closing of the financial accounts for each fiscal year. The term of disclosure is one year from the start day of disclosure.

 

4.         Scope of disclosure and form of disclosure

A Expense for R&D etc

Expense for R&D etc., includes the costs for clinical studies, new drug development and post-marketing clinical studies conducted in compliance with government regulations such as GCP ordinance, Expense for adverse drug reaction (ADR) and infection report, post-marketing surveillance, etc., conducted based on GPSP ordinance, GVP ordinance and official regulations and payment for CRO in relation to such studies and surveillances are also included.

 

Expenses for disclosure

Form

2014

Expense for collaborative researches

Annual total

-

Expense for contract researches

Annual total

-

Expense for clinical studies

Annual total

JPY 5,348,240

Expense for post-marketing clinical studies

Annual total

-

Expense for adverse drug reaction and infections report

Annual total

-

Expense for post-marketing study

Annual total

-

 

B. Expense to promote scientific researches

Donations for educational purposes and general donations for promotion of academic research. Expense for co-hosting medical meetings and donations to support conference such as academic society meeting. Provision of ethical drugs free of charge, in-kind donations, provision of active pharmaceutical ingredients are also included in this category.

  

Expenses for disclosure

Form

2014

Donation for educational purpose

xx lab/seminar of xx University:
number of donations and total amount

-

General donation

xx University (xx Foundation):
number of donations and total amount

-

Donations to support academic conferences

xx th xx conference meeting (xx local meeting, xx study meeting):

total amount

-

Expense for co-hosing medical meeting

xx th xx conference meeting/xx workshop:

Total amount

JPY 2,527,200

 

C Expenses for payment for writing paper, etc.

Expense for lecture, paper, and consultation to disseminate scientific information of in-house medial products, etc.

Expenses for disclosure

Form

2014

Expenses for reward of lectures

Annual total:

xx University xx department/Prof. xx

○○hospital ○○department /head ○○

-

Expense for writing/supervising papers, etc.

Annual total:

xx University xx department/Prof. xx

○○hospital ○○department /head ○○

-

Expense for consigned tasks such as consultation, etc.

Annual total:

xx University xx department/Prof. xx

○○hospital ○○department /head ○○

JPY 406,388

D Expense for information provision

Expense for lecture, explanatory meetings, etc., necessary for providing scientific information on in-house medical product to health professionals.

Expenses for disclosure

Form

2014

Expense for lecture meeting

Frequency and annual total

-

Expense for explanatory meetings

Frequency and annual total

-

Expense of provision of medical /pharmaceutical literatures, etc.

Annual total

-

 

E Other expense

Expense for entertainment etc., as social conventions

Expenses for disclosure

Form

2014

Entertainment expense, etc.

Annual total

-

For request to view the payment detail to HCPs (number of cases, total amount of payments), please contact Lundbeck Japan via email Japan@lundbeck.com with your request.

You are about to leave lundbeck.co.jp